SS-31 (30 mg Vial)

Complete dosage protocol and reconstitution guide for SS-31 (30 mg Vial). Review reconstitution steps, storage guidance, syringe units, and research-use notes.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
SS-31 (30 mg Vial)

CAT No:

CAS No:

Synonyms/Alias:SS-31

M.F/Formula:

M.W/Mr.:

Purity:Specification by inquiry

Custom Peptide Support
  • Sequence, purity and scale confirmation
  • CoA and technical documentation requests
  • API, research and cosmetic peptide options
  • Distributor and institution quotation support

Complete dosage protocol and reconstitution guide for SS-31 (30 mg Vial). Review reconstitution steps, storage guidance, syringe units, and research-use notes.

Quickstart

Reconstitute: Add 3.0 mL bacteriostatic water → ~10 mg/mL concentration for convenient dosing.

Typical daily range: 5–10 mg once daily (gradual titration); advanced protocols may reach 15–20 mg/day under supervision.

Easy measuring: At 10 mg/mL, 1 unit = 0.01 mL = 100 mcg on a U‑100 insulin syringe.

Storage: Lyophilized: freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) ; use within 4 weeks.

Notes

Practical considerations for consistency, safety, and tolerability. Use new sterile insulin syringes for each injection; dispose in a sharps container immediately after use. Rotate injection sites systematically (abdomen, thighs, upper arms) to reduce local irritation and prevent lipohypertrophy [14] . Inject slowly over several seconds; wait briefly before withdrawing the needle to prevent leakage. Mild injection‑site reactions (redness, itching, transient discomfort) are the most common side effects reported in clinical trials [4] [6] ; these typically resolve within hours. Document daily do

Single peptide protocol reference: Available for related research, development or formulation inquiry workflows.

Reconstitution and handling reference: Available for related research, development or formulation inquiry workflows.

Research-use documentation inquiry: Available for related research, development or formulation inquiry workflows.

Source URL
https://peptide.cn.com/single-peptide-dosages/ss-31-30-mg-vial-dosage-protocol
Weeks 1–2
Daily Dose: 5 mg (5000 mcg) | Units (per injection) (mL): 50 units (0.50 mL)
Weeks 3–8
Daily Dose: 10 mg (10,000 mcg) | Units (per injection) (mL): 100 units (1.0 mL)
Long-term Storage Conditions
Lyophilized: freeze at −20 °C (−4 °F) ; after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) ; use within 4 weeks.
Shipping Condition
Shipping conditions by inquiry

Peptide Vials (SS‑31, 30 mg each): 8 weeks (Standard: 5–10 mg/day) ≈ 17 vials

12 weeks (Standard maintenance at 10 mg/day) ≈ 26 vials

12 weeks (Advanced: escalating to 15 mg/day) ≈ 35 vials

Insulin Syringes (U‑100, 1 mL capacity): Per week (standard dosing): 7 syringes (1/day)

8 weeks: 56 syringes

12 weeks: 84 syringes

Advanced protocols with split injections may require 2 syringes per day for higher doses

Bacteriostatic Water (30 mL bottles): Use 3.0 mL per vial for reconstitution. 8 weeks (17 vials): 51 mL → 2 × 30 mL bottles

12 weeks (26 vials): 78 mL → 3 × 30 mL bottles

12 weeks (35 vials, advanced): 105 mL → 4 × 30 mL bottles

Alcohol Swabs: One for the vial stopper + one for the injection site each day. Per week: 14 swabs (2/day)

8 weeks: 112 swabs → recommend 2 × 100‑count boxes

12 weeks: 168 swabs → recommend 2 × 100‑count boxes

Product Gallery
Quick Inquiry
Customer Support & Price Inquiry

Send product, purity, quantity, destination and documentation requirements. Quantai will follow up through WhatsApp or email.

Email: kongq687@gmail.com

WhatsApp Mia WhatsApp Business QR code

Address: Huangpu District, Guangzhou, China